Davis Aaron I.

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
San Diego, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Davis Aaron I.
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Davis Aaron I.

Form 4 holding Director, 10%+ Owner

Odonate Therapeutics, Inc.

Security class
Common Stock
Shares / value
4,607,086
Estimated value
$7,225,754
Report date
19 Nov 2021
Price
$1.57
Ownership
Indirect
Form 4 holding Director, 10%+ Owner

Odonate Therapeutics, Inc.

Security class
Common Stock
Shares / value
445,756
Estimated value
$699,124
Report date
19 Nov 2021
Price
$1.57
Ownership
Direct
Form 4 holding Director

Rain Oncology Inc.

Security class
Common Stock, par value $0.001 per share
Shares / value
0
Estimated value
$0
Report date
26 Jan 2024
Price
$1.21
Ownership
Direct
Form 4 holding Other*

Tango Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
65,000
Estimated value
Report date
03 Sep 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

iTeos Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
24,200
Estimated value
Report date
11 Jun 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Mirati Therapeutics, Inc.

Security class
Option to Purchase Common Stock
Shares / value
0
Estimated value
Report date
23 Jan 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Rain Oncology Inc.

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
26 Jan 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Davis Aaron I.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .